Skip to content

The modulation of endogenous pain inhibitory mechanism by acetaminophen

The modulation of endogenous pain inhibitory mechanism by acetaminophen - The modulation of endogenous pain inhibitory mechanism by acetaminophen

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057378
Enrollment
50
Registered
2025-03-24
Start date
2025-03-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

None listed

Sponsors

Division of Dental Anesthesiology, Department of Diagnostic and Therapeutic Sciences, Meikai University School of Dentistry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: after informed consent is obtained, over 18 years old

Exclusion criteria

Exclusion criteria: The inability to give informed consent, under 18 years old Individuals who have no history of taking acetaminophen and loxoprofen sodium. Individuals who are contraindicated for acetaminophen and loxoprofen sodium - peptic ulcer,serious blood abnormalities,severe liver disorder,severe renal impairment,severe cardiac dysfunction,a history of hypersensitivity to the ingredients of acetaminophen and loxoprofen sodium, aspirin asthma ,women in the late stages of pregnancy. A history of hypersensitivity to the ingredients of lactose hydrate.

Design outcomes

Primary

MeasureTime frame
The evaluation of CPM effect before and after taking acetaminophen. CPM effect is evaluated by pressure pain threshold (PPT) before and during conditioning stimulus.

Secondary

MeasureTime frame
the modulation of QST (the Thermal Pain Illusion(TPI), Temporal Summation(TS), Offset Analgesia(OA) etc) and the effect of background (for example, psychology test including SDS, STAI, PCS etc), and the stress evaluated by catecholamine concentrations in plasma, urine and sweat. As a control, the effect of lactose monohydrate or loxoprofen sodium will be measured on separate days.

Countries

Japan

Contacts

Public ContactYuka Oono

Department of Diagnostic and Therapeutic Sciences, School of Dentistry, Meikai University Division of Dental Anesthesiology

yoono@dent.meikai.ac.jp049-279-2738

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026